Trial intelligence / Profile preview

Propofol vs Sevoflurane Effects on Folic Acid and Homocysteine in Cochlear Implant Surgery

NCT03595163Unknown

Sponsor
Shanghai Ninth People's Hospital
Start
Jan 2018
Primary completion
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of sevoflurane in sensorineural hearing loss (SNHL) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Serum folate levels at Week 1. Status: unknown.

02

Drugs

sevoflurane
03

Conditions

sensorineural hearing loss (SNHL)

Beyond the preview

Go deeper on NCT03595163.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03595163.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call